27Indexed trials
mesh condition
Parkinsonian Disorders
Intelligence
Parkinsonian Disorders intelligence: 27 indexed trials, 10 recruiting studies, 25 sponsors across 25 countries.
10Recruiting
25Sponsors
25Countries
Leading sponsors
Ruijin Hospital21 recruiting
University College, London21 recruiting
Beijing Friendship Hospital10 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
Federal University of Rio Grande do Sul10 recruiting
Fondazione Don Carlo Gnocchi ETS11 recruiting
National Heart, Lung, and Blood Institute (NHLBI)10 recruiting
Institute for Neurodegenerative Disorders10 recruiting
Northwestern University10 recruiting
Novartis Pharmaceuticals10 recruiting
Peking University First Hospital11 recruiting
California Pacific Medical Center Research Institute10 recruiting
Geographic activity
United States16trials
Canada4trials
United Kingdom4trials
China4trials
Spain3trials
Austria3trials
Germany3trials
Italy3trials
France3trials
Hungary2trials
Hong Kong1trials
Belgium1trials
Leading interventions
ADS-51021trials
AFQ0561trials
Acute intermittent hypercapnic hypoxia (AIHH)1trials
Acute intermittent hypercapnic normoxia (AIHN)1trials
Botulinum Neurotoxin Type A1trials
CUE1 non-invasive device1trials
CUE1+ device active vs sham CUE1+ device1trials
Complex eye movement exam1trials
Current standard discharge educational intervention1trials
Dance Program1trials
GAITRite1trials
ADPM1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.